Literature DB >> 10434297

Aggregation of truncated GST-HD exon 1 fusion proteins containing normal range and expanded glutamine repeats.

B Hollenbach1, E Scherzinger, K Schweiger, R Lurz, H Lehrach, E E Wanker.   

Abstract

We have shown previously by electron microscopy that the purified glutathione S-transferase (GST)-Huntington's disease (HD) exon 1 fusion protein with 51 glutamine residues (GST-HD51) is an oligomer, and that site-specific proteolytic cleavage of this fusion protein results in the formation of insoluble more highly ordered protein aggregates with a fibrillar or ribbon-like morphology (E. Scherzinger et al. (1997) Cell 90, 549-558). Here we report that a truncated GST HD exon 1 fusion protein with 51 glutamine residues, which lacks the proline-rich region C-terminal to the polyglutamine (polyQ) tract (GST-HD51 delta P) self-aggregates into high-molecular-mass protein aggregates without prior proteolytic cleavage. Electron micrographs of these protein aggregates revealed thread-like fibrils with a uniform diameter of ca. 25 nm. In contrast, proteolytic cleavage of GST-HD51 delta P resulted in the formation of numerous clusters of high-molecular-mass fibrils with a different, ribbon-like morphology. These structures were reminiscent of prion rods and beta-amyloid fibrils in Alzheimer's disease. In agreement with our previous results with full-length GST-HD exon 1, the truncated fusion proteins GST-HD20 delta P and GST-HD30 delta P did not show any tendency to form more highly ordered structures, either with or without protease treatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10434297      PMCID: PMC1692611          DOI: 10.1098/rstb.1999.0450

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  15 in total

1.  Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats.

Authors:  D C Rubinsztein; J Leggo; R Coles; E Almqvist; V Biancalana; J J Cassiman; K Chotai; M Connarty; D Crauford; A Curtis; D Curtis; M J Davidson; A M Differ; C Dode; A Dodge; M Frontali; N G Ranen; O C Stine; M Sherr; M H Abbott; M L Franz; C A Graham; P S Harper; J C Hedreen; M R Hayden
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

2.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

3.  Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.

Authors:  H L Paulson; M K Perez; Y Trottier; J Q Trojanowski; S H Subramony; S S Das; P Vig; J L Mandel; K H Fischbeck; R N Pittman
Journal:  Neuron       Date:  1997-08       Impact factor: 17.173

4.  Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

Authors:  L Mangiarini; K Sathasivam; M Seller; B Cozens; A Harper; C Hetherington; M Lawton; Y Trottier; H Lehrach; S W Davies; G P Bates
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

5.  Identification of an HD patient with a (CAG)180 repeat expansion and the propagation of highly expanded CAG repeats in lambda phage.

Authors:  K Sathasivam; I Amaechi; L Mangiarini; G Bates
Journal:  Hum Genet       Date:  1997-05       Impact factor: 4.132

Review 6.  Glutamine repeats and inherited neurodegenerative diseases: molecular aspects.

Authors:  M F Perutz
Journal:  Curr Opin Struct Biol       Date:  1996-12       Impact factor: 6.809

7.  Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.

Authors:  E Scherzinger; R Lurz; M Turmaine; L Mangiarini; B Hollenbach; R Hasenbank; G P Bates; S W Davies; H Lehrach; E E Wanker
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

8.  Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

Authors:  S W Davies; M Turmaine; B A Cozens; M DiFiglia; A H Sharp; C A Ross; E Scherzinger; E E Wanker; L Mangiarini; G P Bates
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

9.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

10.  Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length.

Authors:  M W Becher; J A Kotzuk; A H Sharp; S W Davies; G P Bates; D L Price; C A Ross
Journal:  Neurobiol Dis       Date:  1998-04       Impact factor: 5.996

View more
  11 in total

1.  Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy.

Authors:  V Heiser; E Scherzinger; A Boeddrich; E Nordhoff; R Lurz; N Schugardt; H Lehrach; E E Wanker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 2.  Huntingtin in health and disease.

Authors:  Anne B Young
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

3.  Side-chain interactions determine amyloid formation by model polyglutamine peptides in molecular dynamics simulations.

Authors:  Alexander J Marchut; Carol K Hall
Journal:  Biophys J       Date:  2006-03-24       Impact factor: 4.033

4.  Structural features and domain organization of huntingtin fibrils.

Authors:  Charles W Bugg; J Mario Isas; Torsten Fischer; Paul H Patterson; Ralf Langen
Journal:  J Biol Chem       Date:  2012-07-16       Impact factor: 5.157

Review 5.  Huntington's Disease.

Authors:  Steven Finkbeiner
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

6.  Study of the aggregation mechanism of polyglutamine peptides using replica exchange molecular dynamics simulations.

Authors:  Miki Nakano; Kuniyoshi Ebina; Shigenori Tanaka
Journal:  J Mol Model       Date:  2013-01-05       Impact factor: 1.810

Review 7.  Genetic and environmental factors in the pathogenesis of Huntington's disease.

Authors:  Anton van Dellen; Anthony J Hannan
Journal:  Neurogenetics       Date:  2004-01-24       Impact factor: 2.660

8.  An Intein-based Strategy for the Production of Tag-free Huntingtin Exon 1 Proteins Enables New Insights into the Polyglutamine Dependence of Httex1 Aggregation and Fibril Formation.

Authors:  Sophie Vieweg; Annalisa Ansaloni; Zhe-Ming Wang; John B Warner; Hilal A Lashuel
Journal:  J Biol Chem       Date:  2016-03-21       Impact factor: 5.157

9.  Amyloid-like fibril formation by polyQ proteins: a critical balance between the polyQ length and the constraints imposed by the host protein.

Authors:  Natacha Scarafone; Coralie Pain; Anthony Fratamico; Gilles Gaspard; Nursel Yilmaz; Patrice Filée; Moreno Galleni; André Matagne; Mireille Dumoulin
Journal:  PLoS One       Date:  2012-03-09       Impact factor: 3.240

10.  Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance.

Authors:  Cody L Hoop; Hsiang-Kai Lin; Karunakar Kar; Zhipeng Hou; Michelle A Poirier; Ronald Wetzel; Patrick C A van der Wel
Journal:  Biochemistry       Date:  2014-10-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.